Author Page for Rainald Fischer

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION-827359, an Antisense Oligonucleotide Inhibitor of ENaC, in Healthy Volunteers and Patients with Cystic Fibrosis: A Double-Blind, Placebo-Controlled, Dose-Escalation, Phase 1/2a Study

Number of pages: 30 Posted: 20 Apr 2022

Sivagurunathan Sutharsan, Rainald Fischer, Wolfgang Gleiber, Alex Horsley, Jeff Crosby, Shuling Guo, Rosie Yu, Kenneth Newman and Stuart Elborn

University of Duisburg-Essen - Division of Cystic Fibrosis, Ionis Pharmaceuticals, Ionis Pharmaceuticals, The University of Manchester - Wythenshawe Hospital, Ionis Pharmaceuticals, Ionis Pharmaceuticals, Ionis Pharmaceuticals, Ionis Pharmaceuticals and Queen’s University Belfast - Department of Medicine, Health and Life Sciences

Downloads 123 (588,531)

Citation 4

View PDF
Download

Rainald Fischer

Ionis Pharmaceuticals

1

123

4

Scholarly Papers (1)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION-827359, an Antisense Oligonucleotide Inhibitor of ENaC, in Healthy Volunteers and Patients with Cystic Fibrosis: A Double-Blind, Placebo-Controlled, Dose-Escalation, Phase 1/2a Study

Abstract: